carlisle & Associates
generic drug updates News contact carlisle medical
news
generic drug updates
November Generic Drug Release
Released: 11/21/2011
By: Theron Mindek

Authorized Generic of Kadian® Capsules Launches

On November 10th, Watson received final FDA approval and launched their generic version of Kadian® capsules.

-MORPHINE SU ER CAP 20, 30, 50, 60, 80,100MG

Morphine is used to relieve moderate to severe pain. Morphine long-acting tablets and capsules are only used by patients who are expected to need medication to relieve moderate to severe pain around-the-clock for longer than a few days.

Generic Equivalent of Xyzal® Oral Solution Launched

On November 7th, Perrigo Company announced that they received final FDA approval for their Abbreviated New Drug Application (ANDA) for levocetirizine dihydrochloride oral solution. This product is the AB-rated generic version of UCB Pharmaceutical's branded product, Xyzal® oral solution.

-LEVOCET DIHY OS 2.5/55OZ

Xyzal oral solution is indicated for the treatment of indoor and outdoor allergies.

Both Generics are in stock and available to all claimants covered by Carlisle Medical Home Delivery Pharmacy


<<Back
 
Company News Releases
Generic Drug Updates
Newsletter Subscription
Newsletter Login
 
 
 
 
 
© Copyright 2019 Carlisle Medical, Inc.
Twitter Twitter Twitter Twitter
disclaimer site map disclaimer